tmo – Page 3 – Scalper1

Genomics Out Of ‘Caveman Era,’ But Still A Ways To Go

In the field of biotech investing, venture capitalist James Blair is one of the veterans. Working at Rothschild back in the 1980s, Blair was an early investor in Applied Biosystems — now part of Thermo Fisher Scientific (TMO) — which developed the gene sequencers used in the Human Genome Project. He was also an early player in Amgen (AMGN), one of the first companies to use genetic information to hit it big in the drug industry. Since then, he’s

Thermo Fisher, Varian, Abbott Up On Earnings Reports

Three leading medical-equipment stocks were up Thursday after reporting strong Q4 results, though their guidance continued this season’s theme of foreign-exchange headwinds. Life-science toolmaker Thermo Fisher Scientific (TMO) reported earnings minus one-time items of $1.99 a share, up 39% over the year-earlier quarter and beating analysts’ consensus by 5 cents. Sales rose 30% to $4.49 billion, topping estimates by more than $100 million. For the